| HOME >> MEDICINE >> TECHNOLOGY |
Segment - Percentage Breakdown of Dollar Sales for
Penicillin, Cephalosporin, Macrolides, Quinolones,
Carbapenems and Other Antibiotics Markets for 2005, 2010 &
2015 (includes corresponding Graph/Chart) 115
17e. SPAIN 116
Market Analysis 116
Table 58: Spanish Recent Past, Current & Future Analysis for
Antibiotics by Product Segment - Penicillin, Cephalosporin,
Macrolides, Quinolones, Carbapenems and Other Antibiotics
Markets Independently Analyzed with Annual Sales in US$
Million for Years 2007 through 2015 (includes corresponding
Graph/Chart) 116
Table 59: Spanish Historic Review for Antibiotics by Product
Segment - Penicillin, Cephalosporin, Macrolides, Quinolones,
Carbapenems and Other Antibiotics Markets Independently
Analyzed with Annual Sales in US$ Million for Years 2000
through 2006 (includes corresponding Graph/Chart) 117
Table 60: Spanish 11-Year Perspective for Antibiotics by
Product Segment - Percentage Breakdown of Dollar Sales for
Penicillin, Cephalosporin, Macrolides, Quinolones,
Carbapenems and Other Antibiotics Markets for 2005, 2010 &
2015 (includes corresponding Graph/Chart) 118
17f. REST OF EUROPE 119
A. Market Analysis 119
Current and Future Analysis 119
Poland 119
Table 61: Polish Market for Antibiotics (2008): Percentage
Breakdown of Market Share by Leading Companies - GSK
Pharma, Bioton, Sandoz Corp, Ranbaxy and Others (includes
corresponding Graph/Chart) 119
Focus On Select Players 119
B. Market Analytics 120
Table 62: Rest of Europe Recent Past, Current & Future
Analysis for Antibiotics by Product Segment - Penicillin,
Cephalosporin, Macrolides, Quinolones, Carbapenems and Other
Antibiotics Markets Independently Analyzed with Annual Sales
in US$ Million for Years 2007 t
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |